Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calogero Catanzaro

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Urologic Oncology|November 18, 2025
Partial vs. radical nephrectomy in pT3a renal cancer: Cancer-specific mortality according to fat invasion patternMichele Nicolazzini, Calogero Catanzaro, Federico Polverino, et al.
Minerva Urology and Nephrology|June 18, 2025
Feasibility and setting of single docking HUGO RAS robot-assisted nephroureterectomy: first European experienceAngelo Mottaran, Pietro Piazza, Hussam Dababneh, et al.
Cancers|July 27, 2024
Multiparametric Whole-Body MRI: A Game Changer in Metastatic Prostate CancerArrigo Cattabriga, Benedetta Renzetti, Francesco Galuppi, et al.
Journal of Clinical Medicine|March 28, 2026
Cancer-Specific Mortality in Sarcomatoid Renal Cell Carcinoma: A Histological Subtype-Controlled AnalysisMichele Nicolazzini, Calogero Catanzaro, Federico Polverino, et al.
Journal of Endourology|March 2, 2026
Percutaneous Radiofrequency Ablation for Bosniak III-IV Cysts: A 5-Year Institutional ExperienceAttilio Barretta, Pietro Piazza, Andrea Boccatonda, et al.
BJU International|December 26, 2025
Is there still a role for ureteric frozen section analysis during radical cystectomy?Attilio Barretta, Pietro Piazza, Calogero Catanzaro, et al.
World Journal of Urology|November 11, 2025
Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomesQuynh Chi Le, Mattia Longoni, Andrea Marmiroli, et al.
Annals of Surgical Oncology|March 16, 2026
ASO Visual Abstract: Type 2 Diabetes Mellitus Versus Adverse In-Hospital Outcomes After Partial or Radical NephrectomyMaximilian Filzmayer, Michele Nicolazzini, Calogero Catanzaro, et al.
Annals of Surgical Oncology|February 27, 2026
Type 2 Diabetes Mellitus Versus Adverse In-Hospital Outcomes After Partial or Radical NephrectomyMaximilian Filzmayer, Michele Nicolazzini, Calogero Catanzaro, et al.
Annals of Surgical Oncology|March 6, 2026
ASO Author Reflections: Type 2 Diabetes Mellitus and Insulin-Dependence as Determinants of Adverse In-Hospital Outcomes After Partial or Radical NephrectomyMaximilian Filzmayer, Michele Nicolazzini, Calogero Catanzaro, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Urologic Oncology|November 18, 2025
Partial vs. radical nephrectomy in pT3a renal cancer: Cancer-specific mortality according to fat invasion patternMichele Nicolazzini, Calogero Catanzaro, Federico Polverino, et al.
Minerva Urology and Nephrology|June 18, 2025
Feasibility and setting of single docking HUGO RAS robot-assisted nephroureterectomy: first European experienceAngelo Mottaran, Pietro Piazza, Hussam Dababneh, et al.
Cancers|July 27, 2024
Multiparametric Whole-Body MRI: A Game Changer in Metastatic Prostate CancerArrigo Cattabriga, Benedetta Renzetti, Francesco Galuppi, et al.
Journal of Clinical Medicine|March 28, 2026
Cancer-Specific Mortality in Sarcomatoid Renal Cell Carcinoma: A Histological Subtype-Controlled AnalysisMichele Nicolazzini, Calogero Catanzaro, Federico Polverino, et al.
Journal of Endourology|March 2, 2026
Percutaneous Radiofrequency Ablation for Bosniak III-IV Cysts: A 5-Year Institutional ExperienceAttilio Barretta, Pietro Piazza, Andrea Boccatonda, et al.
BJU International|December 26, 2025
Is there still a role for ureteric frozen section analysis during radical cystectomy?Attilio Barretta, Pietro Piazza, Calogero Catanzaro, et al.
World Journal of Urology|November 11, 2025
Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomesQuynh Chi Le, Mattia Longoni, Andrea Marmiroli, et al.
Annals of Surgical Oncology|March 16, 2026
ASO Visual Abstract: Type 2 Diabetes Mellitus Versus Adverse In-Hospital Outcomes After Partial or Radical NephrectomyMaximilian Filzmayer, Michele Nicolazzini, Calogero Catanzaro, et al.
Annals of Surgical Oncology|February 27, 2026
Type 2 Diabetes Mellitus Versus Adverse In-Hospital Outcomes After Partial or Radical NephrectomyMaximilian Filzmayer, Michele Nicolazzini, Calogero Catanzaro, et al.
Annals of Surgical Oncology|March 6, 2026
ASO Author Reflections: Type 2 Diabetes Mellitus and Insulin-Dependence as Determinants of Adverse In-Hospital Outcomes After Partial or Radical NephrectomyMaximilian Filzmayer, Michele Nicolazzini, Calogero Catanzaro, et al.
Pageof 6